Leonie Campbell
AstraZeneca
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Leonie Campbell.
Journal of the American Chemical Society | 2009
Ting Yang; Alessandro Ferrali; Filippo Sladojevich; Leonie Campbell; Darren J. Dixon
A mutually compatible and cooperative combination of copper(I) triflate and bifunctional 9-amino-9-deoxyepicinchona-derived urea compounds for the enantioselective Conia-ene cyclization of alkyne-tethered beta-ketoester substrates is reported. The reaction is efficient, broad in scope, and easy to perform and allows access to chiral methylenecyclopentane products with high enantiocontrol. The transformation illustrates the concept of combining inactive precatalysts with inactive transition-metal-ion complexes in situ to reversibly create a catalytically active combination of the two.
Bioorganic & Medicinal Chemistry Letters | 2009
Richard William Arthur Luke; Peter Ballard; David Buttar; Leonie Campbell; Jon Owen Curwen; Steve Emery; Alison M. Griffen; Lorraine Hassall; Barry R. Hayter; Cliff Jones; William Mccoull; Martine J. Mellor; Michael Lingard Swain; Julie A. Tucker
The SAR and improvement in potency against Tie2 of novel thienopyrimidine and thiazolopyrimidine kinase inhibitors are reported. The crystal structure of one of these compounds bound to the Tie-2 kinase domain is consistent with the SAR. These compounds have moderate potency in cellular assays of Tie-2 inhibition, good physical properties, DMPK, and show evidence of in vivo inhibition of Tie-2.
MedChemComm | 2013
Michael J. Waring; Stuart Norman Lile Bennett; Scott Boyd; Leonie Campbell; Robert D. M. Davies; Stefan Gerhardt; David Hargreaves; Nathaniel G. Martin; Graeme R. Robb; Gary Wilkinson
Successful lead optimisation requires the identification of the best compound within the chemical space explored during an optimisation campaign. This can be a costly and inefficient process leading to the synthesis of many sub-optimal compounds. In this paper, a method for carrying out this exercise more effectively is outlined. This relies on the generation of robust datasets on which to build predictive models in a paradigm termed “matched triplicate design sets”. The practical implementation of this approach is exemplified in the optimisation of a new series of glucokinase activators.
MedChemComm | 2013
Michael J. Waring; Stuart Norman Lile Bennett; Scott Boyd; Leonie Campbell; Robert D. M. Davies; David Hargreaves; Philip A. MacFaul; Nathaniel G. Martin; Derek Ogg; Graeme R. Robb; Gary Wilkinson; J. Matthew Wood
The matched triplicate approach to lead optimisation offers a means of generating more robust quantitative structure activity relationship data and this rigour leads to better quality decision making and greater ability to predict optimal compounds within a series. One of the ultimate aims of this approach is to use the data generated to build more accurate predictive models to identify the best compounds within the exemplified chemical space in an efficient manner. This paper describes the continued application of this approach to the optimisation of a series of glucokinase activators. This second phase focussed primarily on the rational solution to plasma instability observed with the previous compounds and, hence, achieved acceptable oral exposure in the series. The campaign was completed by using the predictive power of Free-Wilson analysis based on the matched triplicate datasets to enable a focussed, matrix based endgame culminating in the identification of two development candidates, AZD3651 and AZD9485.
MedChemComm | 2013
Michael J. Waring; Alan Martin Birch; Susan Birtles; Linda K. Buckett; Roger John Butlin; Leonie Campbell; Pablo Morentin Gutierrez; Paul D. Kemmitt; Andrew G. Leach; Philip A. MacFaul; Charles John O'donnell; Andrew V. Turnbull
Inhibition of diacylglycerol acetyl transferase 1 is of great interest in the treatment of diabetes, obesity and other diseases that constitute the metabolic syndrome. Small molecule inhibitors of the enzyme are often dogged with physicochemical property-related problems such as poor solubility. Herein, the optimisation of a series of biphenyl acetic acid inhibitors is reported. Focus on ligand efficiency and ligand lipophilicity efficiency and a strategy based on conformational restriction led to compounds with excellent potency and ADMET properties, culminating in the discovery of AZD2353.
Angewandte Chemie | 2018
Jonathan R. Carney; Barry. R. Dillon; Leonie Campbell; Stephen P. Thomas
The manganese-catalyzed hydrosilylation and hydroboration of alkenes has been developed using a single manganese(II) precatalyst and reaction protocol. Both reactions proceed with excellent control of regioselectivity and in high yields across a variety of sterically and electronically differentiated substrates (25 examples). Alkoxide activation, using NaOt Bu, was key to precatalyst activation and reactivity. Catalysis was achieved across various functional groups and on gram-scale for both the developed methodologies with catalysts loadings as low as 0.5 mol %.
Journal of the American Chemical Society | 2007
Ting Yang; Leonie Campbell; Darren J. Dixon
Chemical Communications | 2008
Ting Yang; Alessandro Ferrali; Leonie Campbell; Darren J. Dixon
Archive | 2009
Stuart Norman Lile Bennett; Roger John Butlin; Leonie Campbell; Robert D. M. Davies; Graeme R. Robb; Rolf Peter Walker; Michael J. Waring; Helen Pointon; Mikael Dan Brink; Jonas Fägerhag; Ulrik Jurva; Volker Schnecke; Anette Marie Svensson Henriksson; Christer Westerlund; Peter Bonn
Tetrahedron Letters | 2008
Scott Boyd; Leonie Campbell; Wensheng Liao; Qinghong Meng; Zuozhong Peng; Xiaoping Wang; Michael J. Waring